Page last updated: 2024-11-01

norfloxacin and Hyperpotassemia

norfloxacin has been researched along with Hyperpotassemia in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antoniou, T1
Gomes, T1
Mamdani, MM1
Yao, Z1
Hellings, C1
Garg, AX1
Weir, MA1
Juurlink, DN1

Other Studies

1 other study available for norfloxacin and Hyperpotassemia

ArticleYear
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.
    BMJ (Clinical research ed.), 2011, Sep-12, Volume: 343

    Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents, Urinary; Case-Control Studies; Drug Int

2011